1) Future health care will focus on personalized, predictive, preventative care as innovations accelerate and globalization shapes new treatments.
2) Fast emerging technologies like nanomedicine, artificial intelligence, and genomics will enable enhanced health monitoring, more targeted therapies, and longer lifespans.
3) Consumers will have more control over their health data and treatment through self-care tools, genetic testing, and lifestyle management apps and devices.
Partnership e Innovazione nelle Aziende Sanitarie e OspedaliereGiuseppe Orzati
La strategia di innovazione di un'Azienda Sanitaria e Ospedaliera può essere accelerata ed avere maggiore qualità se è aperta e partecipata.
Una grande Azienda Sanitaria Pubblica, quella di Firenze, intende posizionarsi come azienda innovativa di rilievo nazionale e internazionale attraverso il brand "LIS - Laboratorio di Innovazione per la Salute". Nel farlo vuole coinvolgere primari partner privati nell'ambito della tecnologia, industria e del commercio, dei servizi, della farmaceutica e della comunicazione che condividono il progetto strategico e che intendono contribuire a realizzarlo con risorse e conoscenze. dott. Mario Cecchi convegno "lean thinking in ospedale" Firenze 14-15 dicembre 2009" www.asf.toscana.it
Realize preventive medicine through predictive risk profiling, determining baseline markers of wellness and variability, and engaging in personalized pre-clinical interventions
Partnership e Innovazione nelle Aziende Sanitarie e OspedaliereGiuseppe Orzati
La strategia di innovazione di un'Azienda Sanitaria e Ospedaliera può essere accelerata ed avere maggiore qualità se è aperta e partecipata.
Una grande Azienda Sanitaria Pubblica, quella di Firenze, intende posizionarsi come azienda innovativa di rilievo nazionale e internazionale attraverso il brand "LIS - Laboratorio di Innovazione per la Salute". Nel farlo vuole coinvolgere primari partner privati nell'ambito della tecnologia, industria e del commercio, dei servizi, della farmaceutica e della comunicazione che condividono il progetto strategico e che intendono contribuire a realizzarlo con risorse e conoscenze. dott. Mario Cecchi convegno "lean thinking in ospedale" Firenze 14-15 dicembre 2009" www.asf.toscana.it
Realize preventive medicine through predictive risk profiling, determining baseline markers of wellness and variability, and engaging in personalized pre-clinical interventions
Consumerism, Innovation and Best Practices to Thrive in the Future of HealthJustin Barnes
May 1, 2019 University of Toronto, Dalla Lana School of Public Health, The Institute of Health Policy, Management and Evaluation (IHPME) Keynote speaker Justin Barnes, a health innovation strategist and co-founder of Health Innovation Think Tank, will provide yet another integral perspective focused on the ways in which we can scale up and implement evidence-based changes in health care technology on a global scale. Having testified before Congress on more than twenty occasions delivering statements on virtual care, alternative payment methods, consumerism, connected health and the globalization of healthcare, Justin offers thought leadership for the university, the healthcare community as well as other key stakeholders.
Consumer Driven Health – IHPME Research Day
Looks to the Future of Health Care
The trend towards consumer driven health, whether it be mobile apps, wearable devices, or easy access to electronic health records, is changing the landscape of our health care system and the way we think about care.
John Quackenbush, PhD, a professor of biostatistics and computational biology talks about genomics, the human genome and what the study of it means for our understanding of diseases and, specifically, cancer.
Personalized nutrition from DNA - Use your diet to protect you from chronic d...Omar Fogliadini
Eating well made simple
MANAGE YOUR WEIGHT - WITHOUT WORRYING ABOUT CALORIES.
Lose weight
Eat healthier
Boost immunity
Balance hormones
Get allergy control
Relieve indigestion
EATING WELL MADE SIMPLE
Translate your test results into a personalized nutrition plan
Learn what supplements your body really needs
Quit the numbers game. Stop counting calories
MANAGE STRESS AND SLEEP
Use your diet as first defense against chronic conditions
Use food to manage stress and sleep
Identify foods that stress your body
THE SMART WAY TO TAKE CHARGE OF YOUR HEALTH
Get so many insights from your DNA that no doctor could ever tell you
Hear what your body has to say and live better - by your own rules
A healthy lifestyle is especially hard to do alone. Now you've a Personal Health Coach that customizes your advice before you slip from being healthy into the early stage of an illness.
Making DNA data actionable. Genomic intelligence for good health without pill...Omar Fogliadini
THE SMART WAY TO TAKE CHARGE OF YOUR HEALTH
Get so many insights from your DNA that no doctor could ever tell you
Hear what your body has to say and live better - by your own rules
A healthy lifestyle is especially hard to do alone. Now you've a Personal Health Coach that customizes your advice before you slip from being healthy into the early stage of an illness.
A scientific approach to wellness.
Try now.
PERSONALIZED HEALTH
PERSONALIZED NUTRITION
BRAIN POWER PERFORMANCE
Our digital health programs give you access to behavioral coaching via web or mobile, night or day - like having the world’s leading experts on call but tailored to you and your lifestyle.
Suisse Life Science is a biological big data analytics company that has developed a knowledge-discovery platform to extract cause-effect relationships directly from genetic interpretation – and at scale – linking them to lifestyle data from consumer devices in real time to provide actionable recommendations.
Suisse Life Science specializes in making DNA data useful for population health management.
Now, it’s easier than ever to develop innovative consumer products enhanced and personalized through the power of DNA
We help companies and institutions by providing a comprehensive nutritional, metabolic and lifestyle analysis and management program that includes nutrition intake and lifestyle monitoring, followed by a personalized nutritional, chronic disease prevention and fitness recommendations, tailored for the user, informed on their biomarkers and updated - in real-time - with life data from consumer devices (smartphones, wearables…).
Consumer are looking for more control over their health, and with the advent of affordable genetic testing there are new avenues for personalized treatment and precision medicine.
Concerns still remain that patients – and not a few physicians – don't always understand what the genetic results mean and just what to do about them. Even many doctors aren't well-trained in the clinical implications of genetics and genomics. Without burdening yourself, you can now deliver personalized treatments and behavioral health programs with a mobile AI assistant that provides genetic counseling, tailored to the user, and supports your customers 24/7.
What used to take weeks of painstaking manual curation can now be completed in days.
Our technology is ready-to-market and it can be customized according to your specific needs across the aging and age-related disease prevention and management.
We have all-in-one solutions including our proprietary genetic panels - or we can integrate existing inflows of genetic data.
This presentation was presented by Dr. Abdul Nasir Qayyumi - Medical Director for CTTC-Medical Department. This presentation was presented in MoPH to support MoPH's priority of Cancer Screening and Treatment Center to be established in Afghanistan. Presented at 3:00pm,on Sunday, 23rd Dec 2012. www.cttc-af.org
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Consumerism, Innovation and Best Practices to Thrive in the Future of HealthJustin Barnes
May 1, 2019 University of Toronto, Dalla Lana School of Public Health, The Institute of Health Policy, Management and Evaluation (IHPME) Keynote speaker Justin Barnes, a health innovation strategist and co-founder of Health Innovation Think Tank, will provide yet another integral perspective focused on the ways in which we can scale up and implement evidence-based changes in health care technology on a global scale. Having testified before Congress on more than twenty occasions delivering statements on virtual care, alternative payment methods, consumerism, connected health and the globalization of healthcare, Justin offers thought leadership for the university, the healthcare community as well as other key stakeholders.
Consumer Driven Health – IHPME Research Day
Looks to the Future of Health Care
The trend towards consumer driven health, whether it be mobile apps, wearable devices, or easy access to electronic health records, is changing the landscape of our health care system and the way we think about care.
John Quackenbush, PhD, a professor of biostatistics and computational biology talks about genomics, the human genome and what the study of it means for our understanding of diseases and, specifically, cancer.
Personalized nutrition from DNA - Use your diet to protect you from chronic d...Omar Fogliadini
Eating well made simple
MANAGE YOUR WEIGHT - WITHOUT WORRYING ABOUT CALORIES.
Lose weight
Eat healthier
Boost immunity
Balance hormones
Get allergy control
Relieve indigestion
EATING WELL MADE SIMPLE
Translate your test results into a personalized nutrition plan
Learn what supplements your body really needs
Quit the numbers game. Stop counting calories
MANAGE STRESS AND SLEEP
Use your diet as first defense against chronic conditions
Use food to manage stress and sleep
Identify foods that stress your body
THE SMART WAY TO TAKE CHARGE OF YOUR HEALTH
Get so many insights from your DNA that no doctor could ever tell you
Hear what your body has to say and live better - by your own rules
A healthy lifestyle is especially hard to do alone. Now you've a Personal Health Coach that customizes your advice before you slip from being healthy into the early stage of an illness.
Making DNA data actionable. Genomic intelligence for good health without pill...Omar Fogliadini
THE SMART WAY TO TAKE CHARGE OF YOUR HEALTH
Get so many insights from your DNA that no doctor could ever tell you
Hear what your body has to say and live better - by your own rules
A healthy lifestyle is especially hard to do alone. Now you've a Personal Health Coach that customizes your advice before you slip from being healthy into the early stage of an illness.
A scientific approach to wellness.
Try now.
PERSONALIZED HEALTH
PERSONALIZED NUTRITION
BRAIN POWER PERFORMANCE
Our digital health programs give you access to behavioral coaching via web or mobile, night or day - like having the world’s leading experts on call but tailored to you and your lifestyle.
Suisse Life Science is a biological big data analytics company that has developed a knowledge-discovery platform to extract cause-effect relationships directly from genetic interpretation – and at scale – linking them to lifestyle data from consumer devices in real time to provide actionable recommendations.
Suisse Life Science specializes in making DNA data useful for population health management.
Now, it’s easier than ever to develop innovative consumer products enhanced and personalized through the power of DNA
We help companies and institutions by providing a comprehensive nutritional, metabolic and lifestyle analysis and management program that includes nutrition intake and lifestyle monitoring, followed by a personalized nutritional, chronic disease prevention and fitness recommendations, tailored for the user, informed on their biomarkers and updated - in real-time - with life data from consumer devices (smartphones, wearables…).
Consumer are looking for more control over their health, and with the advent of affordable genetic testing there are new avenues for personalized treatment and precision medicine.
Concerns still remain that patients – and not a few physicians – don't always understand what the genetic results mean and just what to do about them. Even many doctors aren't well-trained in the clinical implications of genetics and genomics. Without burdening yourself, you can now deliver personalized treatments and behavioral health programs with a mobile AI assistant that provides genetic counseling, tailored to the user, and supports your customers 24/7.
What used to take weeks of painstaking manual curation can now be completed in days.
Our technology is ready-to-market and it can be customized according to your specific needs across the aging and age-related disease prevention and management.
We have all-in-one solutions including our proprietary genetic panels - or we can integrate existing inflows of genetic data.
This presentation was presented by Dr. Abdul Nasir Qayyumi - Medical Director for CTTC-Medical Department. This presentation was presented in MoPH to support MoPH's priority of Cancer Screening and Treatment Center to be established in Afghanistan. Presented at 3:00pm,on Sunday, 23rd Dec 2012. www.cttc-af.org
Presenter: Marina Sirota, UCSF
Recent advances in genome typing and sequencing technologies have enabled quick generation of a vast amount of molecular data at very low cost. The mining and computational analysis of this type of data can help shape new diagnostic and therapeutic strategies in biomedicine. In this talk, I will discuss how such technological advances in combination with data science and integrative analysis can be applied to drug discovery in the context of drug target identification, computational drug repurposing, and population stratification approaches.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
4. Key Themes
•Globalization of healt care
Globalization th
•Biotech/health Care
convergence
•Health E h
H lth Enhancement &t
Longevity Innovations
•New Era-Predictive H
Health
Care
67. Emerging Co
onsumer Colonoscopy
Mammogramm
PSA screening
Genomics Market Take
T k
preventive
drugs
Genotype Healthier
Algoriithms/
bioinf
formatics
Personalized
disease
screening/
g
medical
Genes intervention
Surrogate Pr
robability
markers of disease
f
Proteomics
P t i
SNPs
Lifestyle
modification
Phenotype Environnment /
Longer
L
family h
history Lives
Quit smoking
Watch nutrition
Exercise
Reduce sun
exposure
68. "Driving M
Medicine Below the
Disease
Symptom Li "
S t m Line"
Progression Po t eat e t test g
ost
o treatment testing
SYMPTOMS
Drug / d
device intervention APPEAR
Diagnosis – prognosis
Screening
Predisposition testing
HEALTHY
Source: Millennium Predictive Medicine; Start-up 2000
69. Post Genomic M
Medicine’s Impact
on Consumers
–
•Predictive
•Consumer empowe
erment
•Lifestyle managem
ment
•Changing how med
dicine is
viewed
70. Conquering Diseease at the
Atomic Scale: D
Designed Care
• From InSilico Biology, to M
Molecular Delivery, to
Intracellular NanoBiology
• The Evolution of Applied NNanoMedicine
79. NanoBioNeuro-De
evices
Enhancement o
a ce e of
HumanPerformance
80. Personal Bio-dete
ection / Predictive
Diagnostics Futur
res
• Biochip Implants
• Proactive Diagnostics - Direct User In
nterface
• Dynamic NanoBio Enhanced Immune System
e
• Molecular Sensors / Nanobiological System Integration
103. Smart Cancer T
Therapeutic
Nanodelivery
Presence in Tumor
• Senses Tumor Cells for Defects
s
• Selects Therapeutic Agents Bas on
sed
Tumor Characteristics
• Non-invasive External Trigger
Releases Therapeutics
•Synergy is predictive
• Identifies Residual Tumor cells
107. Robots & Humans Co Evolution
s: Co-Evolution
Jcanton@futureg
guru.com
guru com
108. Summary
Emerging New era in H
Health Care
Personalized, Predictiv Preventive
ve,
Fast innovations key d
driver of health
q
quality
y
Drugs of the future will be shaped by
globalization